Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. (Q38287309)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

review article

1 reference

title

Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Ellen Otten

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Mirjam Plantinga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Erwin Birnie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Anneke M Lucassen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Adelita V Ranchor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Irene M Van Langen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

11 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

668-678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25503495%20AND%20SRC:MED&resulttype=core&format=json

Duty to disclose in medical genetics: a legal perspective

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

The genetic testing of children for cancer susceptibility: ethical, legal, and social issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Risk reversals in predictive testing for Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Duty to re-contact: a study of families at risk for Fragile X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

The duty to recontact: benefit and harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

The duty to recontact: attitudes of genetics service providers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Genetic registers in clinical practice: a survey of UK clinical genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Provision of genetic services in Europe: current practices and issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Perspectives towards predictive testing in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Impact of a genetic diagnosis of a mitochondrial disorder 5-17 years after the death of an affected child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Ethical issues in ocular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Unprepared, understaffed, and unplanned: thoughts on the practical implications of discovering new breast and ovarian cancer causing genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Whole genome scanning: resolving clinical diagnosis and management amidst complex data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

A clinical perspective on ethical issues in genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

The changing landscape of genetic testing and its impact on clinical and laboratory services and research in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Patient-controlled encrypted genomic data: an approach to advance clinical genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Communicating new knowledge on previously reported genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Whole-genome sequencing and the physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

“I want to know what's in Pandora's box”: Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Pharmacogenomics in children: advantages and challenges of next generation sequencing applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Free the data: one laboratory's approach to knowledge-based genomic variant classification and preparation for EMR integration of genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Managing incidental genomic findings: legal obligations of clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Ethical, legal, and social implications of incorporating genomic information into electronic health records

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

"Use it or lose it" as an alternative approach to protect genetic privacy in personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Roles and responsibilities of a medical geneticist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.173

The coming explosion in genetic testing--is there a duty to recontact?

21 January 2018

1 reference

12 December 2020

Torts and the double helix: malpractice liability for failure to warn of genetic risks.

1 reference

12 December 2020

When information can save lives: the duty to warn relatives about sudden cardiac death and environmental risks

1 reference

12 December 2020

Knowledge about medical genetics in health care

1 reference

12 December 2020

Expanding the physician's duty of care: a duty to recontact?

1 reference

12 December 2020

1 reference

12 December 2020

Duty to recontact: a legal harbinger?

1 reference

12 December 2020

Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics

1 reference

12 December 2020

The duty to re-contact for newly appreciated risk factors: fragile X premutation.

1 reference

12 December 2020

Recontacting patients who have tested negative for BRCA1 and BRCA2 mutations: how, who and why?

1 reference

12 December 2020

BRCA1/2 testing: complex themes in result interpretation

1 reference

12 December 2020

A survey of patients' experiences with the cancer genetic counseling process: recommendations for cancer genetics programs

1 reference

12 December 2020

Legal aspects of genetic information.

1 reference

12 December 2020

Patient preferences regarding recontact by cancer genetics clinicians

1 reference

12 December 2020

Disclosing genetic research results after death of pediatric patients

1 reference

12 December 2020

Duty to disclose to family members in medical genetics

1 reference

12 December 2020

Genetic counseling for breast cancer risk: general concepts, challenging themes and future directions

1 reference

12 December 2020